Encouraging outcomes in older patients following nonmyeloablative haploidentical blood or marrow transplantation
Encouraging outcomes in older patients following nonmyeloablative haploidentical blood or marrow transplantation
Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction
Cancer cells and the immune system: a natural story?
Why are Immuno-Oncology compounds different?
Immuno-Oncology: a concept or already a reality?
Lgr5 stem cells in self-renewal and cancer
ecancermedicalscience Editor's Choice for October 2013
ECC 2013 Preview: Scientific programme highlights
Use of autologous stem cell transplant in multiple myeloma
Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma
Importance of the immune system in cancer
State of CNS germ cell tumour research in North America